Shionogi launches tender for control of C&O
This article was originally published in Scrip
Executive Summary
Shionogi has launched an unconditional general tender offer for the Chinese company C&O Pharmaceutical Technology (Holdings), in line with its acquisition plan for the Hong Kong-based firm announced a month ago.